Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga-68 PSMA PET/CT for Metastatic Adenoid Cystic Carcinoma
NCT06521775Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga-68 gozetotide in adenoid cystic carcinoma (ACC), sponsored by Mayo Clinic. Started Aug 2024; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT06521775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06521775.